Navigation Links
DePuy ASR Lawsuit Update: Rottenstein Law Group LLP Responds to J&J $3 Billion Settlement Report
Date:8/21/2013

(PRWEB) August 21, 2013

Johnson & Johnson is reportedly considering a more than $3 billion DePuy ASR hip implant settlement, according to Bloomberg.* The Rottenstein Law Group LLP, a metal-on-metal hip implant firm, comments on the news and notes that DePuy hip settlements could amount to more than $300,000 per plaintiff.

There are more than 8,000 DePuy ASR lawsuits pending in federal court alone, according to Bloomberg. Johnson & Johnson said in the story it wants to resolve all federal and state cases by early next year. In 2010 Johnson & Johnson recalled 93,000 metal-on-metal hip implants worldwide, about 37,000 of those in the United States, the story said. The ASR had a failure rate of 12 percent after five years.

“There are a handful of ASR bellwether trials coming up this fall and winter,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “It will be interesting to see how they affect this proposed settlement. Ultimately, though, this is a good sign for those looking to file DePuy lawsuits. There is the potential to receive certain compensation for harms suffered as a result of the alleged side effects of the device.”

The ASR, like some other metal-on-metal hip implants, has been under the lens of the U.S. Food and Drug Administration, chiefly because of one dangerous, alleged adverse side effect called “metal poisoning,” or “metallosis.” According to the FDA, cobalt and chromium particles could enter into the implantee’s bloodstream when the device’s metal parts touch each other. This could lead to potentially severe health problems, the FDA said, such as neurological impairment.**

The Rottenstein Law Group LLP represents clients in ASR hip lawsuits. The firm encourages those who believe they have suffered from the ASR’s alleged side effects to visit the firm’s FAQ page to learn more about lawsuits and settlements.

*bloomberg.com/news/2013-08-21/j-j-said-to-weigh-3-billion-settlement-of-its-hip-implant-cases.html (Aug. 12, 2013)

**http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

Read the full story at http://www.prweb.com/releases/depuy-asr-lawsuit/depuy-settlements/prweb11048548.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Possible August 2013 Deadline Ahead for North Carolina DePuy ASR Hip Recall Lawsuits, Product Liability Lawyer Ben Cochran Says
2. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Most Recent Developments in New Jersey DePuy ASR Recall Litigation
3. Plaintiff Furnishes Witness List for First Trial in DePuy ASR Multidistrict Litigation, Reports Parker Waichman LLP
4. US Drug Watchdog Urges Recalled DePuy ASR Hip Implant Recipients To Call Them Immediately If They Live In A State Where The Statute Of Limitations Has Not Yet Run Out
5. New DePuy Metal Hip Implant Lawsuits Allegations Update: Resource4thePeople Reports Important Trial Scheduled in Federal Consolidated Cases
6. DePuy ASR Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Pre-trial Ruling in Federal DePuy ASR Recall Litigation
7. DePuy ASR Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Release of New Pretrial Order in New Jersey DePuy ASR Recall Litigation
8. DePuy ASR Lawsuit News: Rottenstein Law Group LLP Comments on Judge’s Decision to Exclude 2010 ASR Recall from Trial
9. DePuy Pinnacle Hip Lawsuit Filings in Federal Multidistrict Litigation Exceed 4,600, Bernstein Liebhard LLP Reports
10. DePuy Hip Class I Recall Announced By FDA of Its DePuy LPS Lower Extremity Dovetail Intercalary Hip Implant Component Due to Risk of Fracturing, Reports Wright & Schulte
11. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes DePuy Orthopaedic’s Motion for Summary Judgment in California Bellwether Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , ... benign bony lump located on the forehead usually attributed to a facial fracture. Their ... pain. Dr. Shah has discovered an approach that is minimally invasive. He is an ...
(Date:4/21/2017)... ... 2017 , ... Young Asset Protection, an insurance provider and ... greater Pittsburgh metropolitan region, is joining forces with the local chapter of the ... , Variety the Children’s Charity is a national organization dedicated to empowering, enabling, ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl Institute ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions to ... the award at The Beryl Institute’s annual Patient Experience Conference on March ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry ... O2X , an active lifestyle company that provides Human Performance Training and education ... police offers, first responders, military officers and others in service through the development ...
(Date:4/21/2017)... ... April 21, 2017 , ... Airway ... new partnership with the highly regarded and well renowned Asian distributor, Discovery Sleep. ... & myTAP PAP Nasal Pillow Mask, and will stabilize and strengthen Airway’s presence ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology: